compass pointing to compliance

Institutional Biosafety Committee

FAU is committed to compliance with Federal, State and Local guidelines and regulations as they apply to research. Federal Guidelines mandate that any entity receiving federal funding and conducting research with recombinant/synthetic nucleic acid molecules must have an Institutional Biosafety Committee (IBC) to review such activities. The FAU IBC has been delegated the authority to set University policy with regard to research with recombinant/synthetic nucleic acid molecules and biological materials, agents and toxins. The FAU IBC functions include those designated for the IBC in the National Institutes of Health (NIH) Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules, and, consistent with other universities across the country, the control of health hazards associated with the use of biological materials, agents and toxins.

The IBC has recently been reconstituted and is now managed by the Division of Research through the Research Integrity (RI) unit. Research Integrity works hand in hand with the Biological Safety Program, which is seated within the Environmental, Health and Safety (EH&S) office of FAU. The IBC is composed of FAU faculty and non-faculty members, community members and the Biosafety Officer (BSO).

The IBC is charged with reviewing and approving research with recombinant/synthetic nucleic acid molecules and biological materials, agents and toxins. Most work will not require review by the full IBC, but instead will be reviewed and approved by the FAU BSO and/or the IBC Chair.

Will my work require registration with the IBC?

If your work includes use of any of the following, it will require you to fill out an IBC protocol registration form:

  1. Recombinant/Synthetic Nucleic Acid Molecules (including Human Gene Transfer)
  2. Microorganisms (bacteria, viruses, parasites, fungi, prions and rickettsia) infectious to humans, animals or plants
  3. Biologically active agents (toxins or venoms)
  4. Human and/or nonhuman primate materials (blood, cells, tissues, cell lines, OPIM)
  5. Field work with animals
  6. Storage of biological materials, agents or toxins

Will my work require review by the full IBC?

If your work includes use of the following, it will require review by the full IBC at a convened meeting:

  1. Items included in NIH Guidelines (https://osp.od.nih.gov/biotechnology/nih-guidelines/) Sections III-A, B, C, D and E
  2. Infectious organisms included in Risk Groups 3 and 4 (https://my.absa.org/Riskgroups)
  3. Biologically Active Toxins included as Select Agents (https://www.selectagents.gov/SelectAgentsandToxinsList.html)

If you're unsure about needing to register your work, please contact the Biosafety Officer (fnovembre@fau.edu; (561)297-2936) for guidance.

When will my protocol be reviewed?

All protocols submitted to the IBC will receive a primary review by the BSO. If there are any issues with the protocol (i.e., erroneous information, incomplete protocol, etc.) the BSO will contact the PI with instructions on the necessary corrections. Once a complete protocol has been submitted, those requiring full IBC review will be sent to the IBC and reviewed at the next meeting, provided that the deadline has been met (see below for meeting dates and deadlines). Those protocols not requiring full IBC review will be reviewed and approved by the BSO and/or IBC Chair within several days.

The IBC has recently been reconstituted and is now managed by the Division of Research through the Research Integrity (RI) unit. Research Integrity is working with the Biological Safety Program in EH&S with the intention of creating an updated approach to supporting the biological research community at FAU.

IBC Submission Deadlines IBC Meeting Dates
March 3, 2020 March 10, 2020
March 23, 2020 March 30, 2020
April 14, 2020 April 21, 2020
May 19. 2020 May 26. 2020
June 4, 2020 June 11, 2020
July 7, 2020 July 14, 2020